Expanded Natural Killer (NK) Cells for Multiple Myeloma Study
NCT01040026
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
OTHER:
Treatment with in vitro expanded haploidentical NK cells
Sponsor
University Hospital, Basel, Switzerland